Globus Medical has completed its acquisition of Nevro, broadening its market presence in musculoskeletal solutions.

The acquisition of Nevro further expands Globus Medical's presence in the musculoskeletal market, unlocking a $2.5 billion market opportunity. This strategic move positions Globus to further add to ...

The acquisition of Vyrsa Technologies in December 2023 enabled Nevro to introduce a complementary line of products aimed at ...

Nevro is a medical device company headquartered in Redwood City, California. If you received a data breach notice letter and wish to discuss this action, obtain further information, and/or ...

Shares of Nevro Corp. (NYSE:NVRO – Get Free Report) have earned a consensus rating of “Reduce” from the thirteen brokerages that are presently covering the firm, Marketbeat.com reports. Two investment ...

On April 3, 2025, Nevro Corp. filed a notice of data breach with the Attorney General of Texas after discovering that information in the company’s possession was subject to unauthorized access.

Nevro NVRO is well-poised for growth in the coming quarters, courtesy of its business expansion plans and restructuring activities. The optimism, led by a decent preliminary full-year 2024 results ...